Y-Intercept (HK)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,115
Closed -$542K 1368
2022
Q4
$542K Buy
+8,115
New +$542K 0.08% 409